Area of expertise and the Healthcare Provider’s contribution to care for patients within the MetabERN Network
Mainz, GERMANY
Area of expertise and the Healthcare Provider’s contribution to care for patients within the MetabERN Network
The Villa Metabolica at the University Medical Center Mainz has a long tradition in taking care of patients with lysosomal storage disorders. As lysosomal storage disorders are general multiorgan diseases, the Villa Metabolica has a close and continuous cooperation with several different departments of the University Medical Center Mainz for diagnosing and treating these patients. Patients being treated in the Villa Metabolica come from whole Germany and different European countries.
The Villa Metabolica offers specialized and newly established treatment for patients with Lysosomal storage disorders, e.g. enzyme replacement therapy. The center is involved in several clinical trials for developing new treatment options for patients with lysosomal storage disorders, e.g. new enzyme replacement therapy for Fabry disease, alpha-mannosidosis, or new treatment options for patients with mucopolysaccharidoses. Furthermore, the Villa Metabolica takes part in different natural history and clinical outcome studies.
The Villa Metabolica has been involved in the development of different guidelines in the treatment of inborn errors of metabolism, especially lysosomal storage disorders. Scientifically, the center focuses on the development of new treatment options in lysosomal storage disorders. Furthermore, the center is involved in research in phenylketonuria and in nonketotic hyperglycinemia.
There is a long standing tradition of close cooperation with the patient support groups being active in the field of lysosomal storage disorders.
SPECIFIC TREATMENTS AND INTERVENTIONS PROVIDED BY THE HCPs